Daniele Pastori | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Association of proprotein convertase subtilisin/kexin type 9 (PCSK9) levels with abnormally high ankle-brachial index in atrial fibrillation	KARDIOLOGIA POLSKA	2023
Medium-term and long-term renal function changes with direct oral anticoagulants in elderly patients with atrial fibrillation	FRONTIERS IN PHARMACOLOGY	2023
Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry	JOURNAL OF THROMBOSIS AND THROMBOLYSIS	2023
Aging and Antithrombotic Treatment	ANTIOXIDANTS & REDOX SIGNALING	2023
Renin‐angiotensin-aldosterone system inhibitors and mortality risk in elderly patients with atrial fibrillation. Insights from the nationwide START registry	EUROPEAN JOURNAL OF INTERNAL MEDICINE	2023
Low-grade endotoxemia and risk of recurrent thrombosis in primary antiphospholipid syndrome. The multicenter ATHERO-APS study	THROMBOSIS RESEARCH	2023
Risk of venous thromboembolism in autoimmune diseases: A comprehensive review	AUTOIMMUNITY REVIEWS	2023
Statins under-treatment and mortality in patients with atrial fibrillation. Insights from the nationwide START registry	NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES	2023
Effect of digoxin on all-cause and cardiovascular mortality in patients with atrial fibrillation with and without heart failure: an umbrella review of systematic reviews and 12 meta-analyses	EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY	2023
Factor V Leiden, prothrombin, MTHFR, and PAI-1 gene polymorphisms in patients with arterial disease: A comprehensive systematic-review and meta-analysis	THROMBOSIS RESEARCH	2023
Efficacy and safety of direct oral anticoagulants in the pediatric population: a systematic review and a meta-analysis	JOURNAL OF THROMBOSIS AND HAEMOSTASIS	2023
Gut barrier dysfunction and endotoxemia in heart failure: A dangerous connubium?	AMERICAN HEART JOURNAL	2023
Venous Thromboembolism in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis of 4,170,027 Patients		2023
Adherence to the 'atrial fibrillation better care' pathway in patients with atrial fibrillation. impact on clinical outcomes-a systematic review and meta-analysis of 285,000 patients	THROMBOSIS AND HAEMOSTASIS	2022
Statin liver safety in non-alcoholic fatty liver disease: a systematic review and metanalysis	BRITISH JOURNAL OF CLINICAL PHARMACOLOGY	2022
Cardiac and vascular features of arterial and venous primary antiphospholipid syndrome. The multicenter ATHERO-APS study	THROMBOSIS RESEARCH	2022
Plasma homocysteine in Behcet's disease: a systematic review and meta-analysis	THROMBOSIS AND HAEMOSTASIS	2022
REPLY to “Association Between Plasmatic Oxidative Stress and Thrombosis in Primary Antiphospholipid Syndrome”	JOURNAL OF THROMBOSIS AND THROMBOLYSIS	2022
Added fructose in non-alcoholic fatty liver disease and in metabolic sindrome. a narrative review	NUTRIENTS	2022
A Meta-Analysis of Plasma Homocysteine in Buerger's Disease	THROMBOSIS AND HAEMOSTASIS	2022

ERC

LS4
LS4_10
LS7
LS7_10

Keywords

cardiovascular disease

anticoagulation

Novel oral anticoagulants

atrial fibrillation

atherosclerosis

NAFLD

NASH

antiphospholipid antibody syndrome

ischemic heart disease

cardiovascular risk

Thrombosis

Atherothrombosis

Progetti di Ricerca

Liver fibrosis and in-hospital outcomes in patients with acute coronary syndrome
Relationship between PCSK9 levels and major cardiovascular and cerebrovascular events (MACCE) in patients with non-alcoholic fatty liver disease (NAFLD): a prospective cohort study.